The acute intermittent porphyria market is estimated to be valued at USD 1.52 Billion in 2025 and is expected to reach USD 2.33 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032. https://timessquarereporter.com/news/acute-intermittent-porphyria-market-is-anticipated-to-witness-high-growth-owing-to-novel-therapeutics